Guardian Pharmacy Services (GRDN) to Release Quarterly Earnings on Wednesday

Guardian Pharmacy Services (NYSE:GRDN) is expected to issue its Q4 2025 results after the market closes on Wednesday, March 11th. Analysts expect the company to announce earnings of $0.27 per share and revenue of $390.0410 million for the quarter. Interested persons may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Wednesday, March 11, 2026 at 4:30 PM ET.

Guardian Pharmacy Services Stock Up 1.6%

Shares of Guardian Pharmacy Services stock opened at $32.29 on Tuesday. The business has a fifty day simple moving average of $31.66 and a 200 day simple moving average of $29.23. The stock has a market cap of $2.04 billion, a PE ratio of 51.25 and a beta of 0.85. Guardian Pharmacy Services has a 12 month low of $18.00 and a 12 month high of $37.43.

Institutional Investors Weigh In On Guardian Pharmacy Services

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Intech Investment Management LLC acquired a new position in Guardian Pharmacy Services during the 4th quarter worth approximately $223,000. Quantbot Technologies LP bought a new position in shares of Guardian Pharmacy Services during the 2nd quarter worth approximately $214,000. The Manufacturers Life Insurance Company acquired a new stake in shares of Guardian Pharmacy Services in the fourth quarter valued at approximately $212,000. Schonfeld Strategic Advisors LLC acquired a new stake in shares of Guardian Pharmacy Services in the third quarter valued at approximately $211,000. Finally, JPMorgan Chase & Co. lifted its position in shares of Guardian Pharmacy Services by 31.1% in the third quarter. JPMorgan Chase & Co. now owns 7,899 shares of the company’s stock worth $207,000 after purchasing an additional 1,872 shares in the last quarter.

Analyst Ratings Changes

GRDN has been the subject of several analyst reports. Truist Financial boosted their target price on Guardian Pharmacy Services from $30.00 to $34.00 and gave the stock a “buy” rating in a research report on Friday, November 14th. Wall Street Zen upgraded shares of Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a research report on Monday, November 17th. Weiss Ratings restated a “hold (c+)” rating on shares of Guardian Pharmacy Services in a report on Monday, December 29th. Finally, Stephens upped their target price on shares of Guardian Pharmacy Services from $35.00 to $36.00 and gave the company an “overweight” rating in a research note on Wednesday, January 14th. Four research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, Guardian Pharmacy Services has an average rating of “Moderate Buy” and an average target price of $32.00.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.